These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Modulation of in vitro platelet 5-HT release by species of Erythrina and Cymbopogon. Rogers KL; Grice ID; Griffiths LR Life Sci; 2001 Aug; 69(15):1817-29. PubMed ID: 11665843 [TBL] [Abstract][Full Text] [Related]
47. On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP. Ishii-Watabe A; Uchida E; Mizuguchi H; Hayakawa T Biochem Pharmacol; 2000 Jun; 59(11):1345-55. PubMed ID: 10751543 [TBL] [Abstract][Full Text] [Related]
48. Platelet reactivity to "in vitro" allergen challenge in asthmatic patients. de Sousa JR; Santos MC; Carlos ML; Carlos AG Allergol Immunopathol (Madr); 1992; 20(1):13-6. PubMed ID: 1387285 [TBL] [Abstract][Full Text] [Related]
49. Effects of heparin on platelet aggregation and release and thromboxane A2 production. Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300 [TBL] [Abstract][Full Text] [Related]
50. Stimulation of postmortem platelets with adenosine-5-diphosphate and epinephrine. Thomsen H; Schmidtke E Forensic Sci Int; 1997 Sep; 89(1-2):47-55. PubMed ID: 9306663 [TBL] [Abstract][Full Text] [Related]
51. Storage of platelets for tests of platelet function: effects of pH on platelet aggregation and liberation of beta-thromboglobulin. Watts SE; Tunbridge LJ; Lloyd JV Thromb Res; 1983 Feb; 29(3):343-53. PubMed ID: 6221437 [TBL] [Abstract][Full Text] [Related]
52. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase. Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346 [TBL] [Abstract][Full Text] [Related]
53. Platelet aggregation induced by ADP or epinephrine is enhanced in habitual smokers. Fusegawa Y; Handa S Thromb Res; 2000 Mar; 97(5):287-95. PubMed ID: 10709904 [TBL] [Abstract][Full Text] [Related]
54. [Effect of the new antimigraine drug serotonin receptor antagonist tropoxin on platelet aggregation]. Vasil'eva TM; Petrukhina GN; Miftakhova NT; Makarov VA; Gan'shina TS; Bezhanian SG; Mirzoian RS Eksp Klin Farmakol; 2005; 68(3):30-3. PubMed ID: 16047677 [TBL] [Abstract][Full Text] [Related]
55. Platelet function testing in the pony. Boudreaux MK; Wagner-Mann C; Purohit R; Hankes G; Spano J; Pablo L; Lee S; Conti J Lab Anim Sci; 1988 Aug; 38(4):448-51. PubMed ID: 3184855 [TBL] [Abstract][Full Text] [Related]
57. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. Krishnamurthi S; Westwick J; Kakkar VV Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666 [TBL] [Abstract][Full Text] [Related]
58. Epinephrine potentiates human platelet activation but is not an aggregating agent. Lanza F; Beretz A; Stierlé A; Hanau D; Kubina M; Cazenave JP Am J Physiol; 1988 Dec; 255(6 Pt 2):H1276-88. PubMed ID: 3202191 [TBL] [Abstract][Full Text] [Related]
59. Selective PF4 release in vitro induced by heparin and related glycosaminoglycans (GAGs)--correlation with beta-TG release and platelet aggregation. Cofrancesco E; Colombi M; Cristoforetti G; Pogliani EM Thromb Haemost; 1984 Feb; 51(1):105-7. PubMed ID: 6202020 [TBL] [Abstract][Full Text] [Related]